Antimicrobial resistance in veterinary medicine

Cardiac valves - Notified Body 0344 - 20/12/2025 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)

Female contraceptive - Notified Body 0123 - 08/05/2025 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)

Human medicines European public assessment report (EPAR): Olazax, olanzapine, Date of authorisation: 11/12/2009, Revision: 14, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Nobivac NXT HCPCh, feline calicivirosis, feline rhinotracheitis, feline panleucopenia and feline chlamydiosis (live) vaccine, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Nobivac NXT HCP, felid herpesvirus 1, strain G2620A, live,feline calicivirus, strain F9, live,feline panleucopenia virus, strain MW-1, live, Status: Authorised

Human medicines European public assessment report (EPAR): Desloratadine Actavis, desloratadine, Date of authorisation: 13/01/2012, Revision: 17, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Nobivac NXT HC, feline calicivirosis and feline viral rhinotracheitis vaccine (live), Status: Authorised

Human medicines European public assessment report (EPAR): Desloratadine ratiopharm, desloratadine, Date of authorisation: 13/01/2012, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Fycompa, perampanel, Date of authorisation: 23/07/2012, Revision: 36, Status: Authorised